Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China · Delayed Price · Currency is CNY 35.00
+0.55 (1.60%)
At close: Nov 13, 2026
SHA:603014 Market Cap
SHA:603014 has a market cap or net worth of 14.62 billion as of November 13, 2026. It is the 6,254th most valuable company in the world and the 1,112th biggest in China. Its market cap has decreased by 18.85% in one year.
Market Cap
14.62B
Enterprise Value
11.09B
Revenue
5.40B
Global Rank
Country Rank
#1,112 China
PE Ratio
21.48
ChartMarket Cap Chart
Since May 19, 2025, SHA:603014's market cap has decreased from 17.04B to 14.62B, a decrease of -14.17%. That is a compound annual growth rate of -9.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 14.62B | -11.68% |
| Dec 31, 2025 | 16.56B | -2.82% |
| May 19, 2025 | 17.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lepu Medical Technology (Beijing) | 22.43B |
| Autobio Diagnostics | 21.84B |
| Double Medical Technology | 16.34B |
| Jafron Biomedical | 14.91B |
| MeHow Innovative | 13.48B |
| Insight Lifetech | 11.68B |
| Cofoe Medical Technology | 10.53B |
| Shanghai MicroPort Endovascular MedTech | 10.31B |